{rfName}

Indexed in

License and use

Altmetrics

Grant support

We thank members of the Endothelial Pathobiology and Microenvironment Group for helpful discussions. We thank the CERCA Program/Generalitat de Catalunya and the Josep Carreras Foundation for institutional support. The research leading to these results has received funding from la Fundacion BBVA (Ayuda Fundacion BBVA a Equipos de Investigacion Cientifica 2019, PR19BIOMET0061) and from SAF2017-82072-ERC from Ministerio de Ciencia, Innovacion y Universidades (MCIU) (Spain). The laboratory of M.G. is also supported by the research grants SAF2017-89116R-P (FEDER/EU) co-funded by European Regional Developmental Fund (ERDF), a Way to Build Europe and PID2020-116184RB-I00 from MCEI; by the Catalan Government through the project 2017-SGR; PTEN Research Foundation (BRR-17-001); La Caixa Foundation (HR19-00120 and HR21-00046); by la Asociacion Espanola contra el Cancer-Grupos Traslacionales (GCTRA18006CARR, also to A.C.); European Foundation for the Study of Diabetes/Lilly research grant, also to M.C.); and by the People Programme (Marie Curie Actions; grant agreement 317250) of the European Union's Seventh Framework Programme FP7/2007-2013 and the Marie Sklodowska-Curie (grant agreement 675392) of the European Union's Horizon 2020 research. The laboratory of A.C. is supported by the Basque Department of Industry, Tourism and Trade (Elkartek) and the department of education (IKERTALDE IT1106-16), the MCIU (PID2019-108787RB-I00 (FEDER/EU); Severo Ochoa Excellence Accreditation SEV-2016-0644; Excellence Networks SAF2016-81975-REDT), La Caixa Foundation (ID 100010434), under the agreement LCF/PR/HR17, the Vencer el Cancer foundation and the European Research Council (ERC) (consolidator grant 819242). CIBERONC was co-funded with FEDER funds and funded by Instituto de Salud Carlos III (ISCIII). The laboratory of M.C. is supported by the ERC under the European Union's Horizon 2020 research and innovation programme (grant agreement 725004) and CERCA Programme/Generalitat de Catalunya (M.C.). The laboratory of D.S. is supported by research grants from MINECO (SAF201783813-C3-1-R, also to L.H., cofounded by the ERDF), CIBEROBN (CB06/03/0001), Government of Catalonia (2017SGR278) and Fundacio La Marato de TV3 (20162730). The laboratory of R.N. is supported by FEDER/Ministerio de Ciencia, Innovacion y Universidades-Agencia Estatal de Investigacion (RTI2018-099413-B-I00 and and RED2018-102379-T), Xunta de Galicia (2016-PG057 and 2020-PG015), ERC under the European Union's Horizon 2020 research and innovation programme (grant agreement 810331), Fundacion BBVA, Fundacion Atresmedia and CIBEROBN, which is an initiative of the ISCIII of Spain, which is supported by FEDER funds. The laboratory of J.A.V. is supported by research grants from MICINN (RTI2018-099250-B100) and by La Caixa Foundation (ID 100010434, LCF/PR/HR17/52150009). P.M.G.-R. is supported by ISCIII grant PI15/00701 cofinanced by the ERDF, A Way to Build Europe. Personal support was from Marie Curie ITN Actions (E.M.), Juan de la Cierva (IJCI-2015-23455, P.V.), CONICYT fellowship from Chile (S.Z.), Vetenskapsradet (Swedish Research Council, 2018-06591, L.G.) and NCI K99/R00 Pathway to Independence Award (K99CA245122, P. Castel).

Analysis of institutional authors

Martínez-Romero AAuthorChivite IAuthorOsorio-Conles OAuthorVidal JAuthorClaret MAuthor
Share
Publications
>
Article

Angiocrine polyamine production regulates adiposity

Publicated to:Nature Metabolism. 4 (3): 327-+ - 2022-03-14 4(3), DOI: 10.1038/s42255-022-00544-6

Authors: Monelli, Erika; Villacampa, Pilar; Zabala-Letona, Amaia; Martinez-Romero, Anabel; Llena, Judith; Beiroa, Daniel; Gouveia, Leonor; Chivite, Inigo; Zagmutt, Sebastian; Gama-Perez, Pau; Osorio-Conles, Oscar; Muixi, Laia; Martinez-Gonzalez, Ainara; Castillo, Sandra D; Martin-Martin, Natalia; Castel, Pau; Valcarcel-Jimenez, Lorea; Garcia-Gonzalez, Irene; Villena, Josep A; Fernandez-Ruiz, Sonia; Serra, Dolors; Herrero, Laura; Benedito, Rui; Garcia-Roves, Pablo; Vidal, Josep; Cohen, Paul; Nogueiras, Ruben; Claret, Marc; Carracedo, Arkaitz; Graupera, Mariona

Affiliations

Basque Fdn Sci, IKERBASQUE, Bilbao, Spain - Author
Basque Res & Technol Alliance BRTA, Ctr Cooperat Res Biosci CIC BioGUNE, Bizkaia Technol Pk, Derio, Spain - Author
Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain - Author
Biocruces Bizkaia Hlth Res Inst, Traslat Prostate Canc Res Lab, CIC BioGUNE Basurto, Baracaldo, Spain - Author
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain. - Author
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain. - Author
Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain. - Author
Ctr Nacl Invest Cardiovasc CNIC, Mol Genet Angiogenesis Grp, Madrid, Spain - Author
Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences, Institut de Biomedicina de la Universitat de Barcelona (IBUB), Universitat de Barcelona, Barcelona, Spain. - Author
Department of Endocrinology, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain. - Author
Ikerbasque - Author
Inst Invest Biomed August Pi & Sunyer IDIBAPS, Neuronal Control Metab Lab, Barcelona, Spain - Author
Inst Salud Carlos III, Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain - Author
Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain - Author
Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain - Author
Josep Carreras Leukaemia Res Inst IJC, Endothelial Pathobiol & Microenviroment Grp, Barcelona, Spain - Author
Laboratory of Metabolism and Obesity, Vall d'Hebron-Institut de Recerca, Universitat Autònoma de Barcelona, Barcelona, Spain. - Author
Neuronal Control of Metabolism Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. - Author
NYU, Grossman Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA - Author
Rockefeller Univ, Lab Mol Metab, 1230 York Ave, New York, NY 10021 USA - Author
Univ Autonoma Barcelona, Vall dHebron Inst Recerca, Lab Metab & Obes, Barcelona, Spain - Author
Univ Barcelona, Fac Med & Hlth Sci, Dept Physiol Sci, Barcelona, Spain - Author
Univ Barcelona, Hosp Clin, Dept Endocrinol, IDIBAPS, Barcelona, Spain - Author
Univ Barcelona, Inst Biomed Univ Barcelona IBUB, Sch Pharm & Food Sci, Dept Biochem & Physiol, Barcelona, Spain - Author
Univ Basque Country UPV EHU, Biochem & Mol Biol Dept, Bilbao, Spain - Author
Univ Santiago de Compostela, CIMUS, Inst Invest Sanitaria, Santiago De Compostela, Spain - Author
Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, Uppsala, Sweden - Author
Xunta Galicia, Galician Agcy Invest, La Coruna, Spain - Author
See more

Abstract

Reciprocal interactions between endothelial cells (ECs) and adipocytes are fundamental to maintain white adipose tissue (WAT) homeostasis, as illustrated by the activation of angiogenesis upon WAT expansion, a process that is impaired in obesity. However, the molecular mechanisms underlying the crosstalk between ECs and adipocytes remain poorly understood. Here, we show that local production of polyamines in ECs stimulates adipocyte lipolysis and regulates WAT homeostasis in mice. We promote enhanced cell-autonomous angiogenesis by deleting Pten in the murine endothelium. Endothelial Pten loss leads to a WAT-selective phenotype, characterized by reduced body weight and adiposity in pathophysiological conditions. This phenotype stems from enhanced fatty acid ?-oxidation in ECs concomitant with a paracrine lipolytic action on adipocytes, accounting for reduced adiposity. Combined analysis of murine models, isolated ECs and human specimens reveals that WAT lipolysis is mediated by mTORC1-dependent production of polyamines by ECs. Our results indicate that angiocrine metabolic signals are important for WAT homeostasis and organismal metabolism.© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Keywords
activationdietexpressionmetabolismmodulationobesityreceptorstissue massvegfAdenosylmethionine decarboxylase 1Adipose tissueAdiposityAfimoxifeneAlbumaxAngiocrine polyamineAnimalAnimal experimentAnimal modelAnimalsArticleBlood glucose monitoringBody compositionC57bl mouseCalorimetryCell differentiationCell proliferationCentrifugationControlled studyElectron transportEndothelial cellsEndothelium cellEtomoxirFeces analysisGene deletionGlucoseHemagglutininImmunoblottingInduced angiogenesisLipid dietLipid oxidationLipolysisLiquid chromatography-mass spectrometryLocomotionMalabsorptionMaleMammalian target of rapamycin complex 1MetabolismMiceMice, inbred c57blMitochondrial respirationMouseNonhumanNuclear magnetic resonance imagingObesityPhosphatase and tensin homologPi3k/akt signalingPolyacrylamide gel electrophoresisPolyaminePolyaminesPropranololProteinReagentReal time polymerase chain reactionRespirometrySardomozideSpermidineTamoxifenThermogenesisTriacylglycerolUnclassified drugVascularizationWestern blottingWhite adipose tissue

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Nature Metabolism due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2022, it was in position 4/145, thus managing to position itself as a Q1 (Primer Cuartil), in the category Endocrinology & Metabolism. Notably, the journal is positioned above the 90th percentile.

From a relative perspective, and based on the normalized impact indicator calculated from World Citations provided by WoS (ESI, Clarivate), it yields a value for the citation normalization relative to the expected citation rate of: 3.87. This indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: ESI Nov 14, 2024)

This information is reinforced by other indicators of the same type, which, although dynamic over time and dependent on the set of average global citations at the time of their calculation, consistently position the work at some point among the top 50% most cited in its field:

  • Weighted Average of Normalized Impact by the Scopus agency: 3.09 (source consulted: FECYT Feb 2024)
  • Field Citation Ratio (FCR) from Dimensions: 22.13 (source consulted: Dimensions May 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-05-18, the following number of citations:

  • WoS: 38
  • Scopus: 43
  • Europe PMC: 17
Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-05-18:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 87.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 87 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 139.35.
  • The number of mentions on the social network Facebook: 1 (Altmetric).
  • The number of mentions on the social network X (formerly Twitter): 149 (Altmetric).
Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Sweden; United States of America.